| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.9M | +52.0% |
| R&D Expense | $74.1M | +92.1% |
| SG&A Expense | $29.5M | -25.8% |
| Operating Income | -$88.7M | -242.5% |
| Net Income | -$86.9M | -336.9% |
| EPS (Basic) | -$2.59 | -2490.0% |
| EPS (Diluted) | -$2.59 | -2490.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $77.6M | -31.1% |
| Short-term Investments | $0 | -100.0% |
| Current Assets | $80.5M | -57.5% |
| Total Assets | $89.6M | -52.7% |
| Current Liabilities | $15.9M | -48.7% |
| Total Liabilities | $63.0M | +103.4% |
| Stockholders' Equity | $26.5M | -83.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$81.2M | -426.1% |
| Capital Expenditures | $1.1M | -75.7% |
| Investing Cash Flow | $72.4M | +234.2% |
| Financing Cash Flow | $62.2M | — |
| Free Cash Flow | -$82.3M | -506.8% |